16.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SRPT Giù?
Forum
Previsione
Frazionamento azionario
Sarepta Therapeutics Inc Azioni (SRPT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
10.91%
442.93
|
399.36 | 611.09 | 744.86 | 658.41 |
| Cost Of Revenue |
162.11%
472.04
|
180.09 | 250.53 | 270.90 | - |
| Gross Profit |
113.27%
-29.10
|
219.27 | 360.56 | 473.96 | - |
|
|
64.90%
829.02
|
502.75 | 495.51 | 1,045.24 | 496.73 |
| Interest Income/Expense |
2,207%
-40.04
|
1.90 | 5.228 | -4.503 | -32.31 |
| Benefits Costs and Expenses |
-
|
- | - | - | 486.67 |
| Costs And Expenses |
100.00%
-
|
502.75 | 495.51 | 1,045.24 | 496.73 |
| Operating Income/Loss |
298.09%
-411.58
|
-103.39 | 115.58 | -300.39 | 161.68 |
| Nonoperating Income/Loss |
247.02%
133.29
|
-90.66 | 38.06 | -83.13 | 10.06 |
| Income/Loss From Continuing Operations Before Tax |
328.26%
442.93
|
-194.05 | 153.64 | -383.52 | 171.74 |
| Income Tax Expense/Benefit |
132.27%
4.551
|
-14.10 | -43.25 | 63.99 | 12.69 |
| Income/Loss From Continuing Operations After Tax |
715.19%
-412.23
|
-50.57 | 196.89 | -447.51 | 159.05 |
|
|
715.19%
-412.23
|
-50.57 | 196.89 | -447.51 | 159.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
98.43%
1.575
|
100.24 | 98.00 | 97.36 | 0.406 |
| Diluted Average Shares |
98.43%
1.575
|
100.24 | 106.62 | 97.36 | 8.303 |
| Basic Earnings Per Share |
686.00%
-3.93
|
-0.50 | 2.01 | -4.60 | 1.67 |
| Diluted Earnings Per Share |
686.00%
-3.93
|
-0.50 | 1.89 | -4.60 | 1.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):